BeBetter, Trinomab Advance IPOs On China’s STAR Market In Firsts Since Policy Easing

 
• By Dexter Jie Yan
  
Going public
BeBetter Med and Zhuhai Trinomab Pharmaceutical are a step closer to IPOs on the STAR Market of Shanghai Stock Exchange. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business